Authors:
Fujiwara, K
Yokosuka, O
Fukai, K
Imazeki, F
Saisho, H
Omata, M
Citation: K. Fujiwara et al., Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis, J HEPATOL, 35(1), 2001, pp. 112-119
Authors:
Kawai, S
Yokosuka, O
Imazeki, F
Maru, Y
Saisho, H
Citation: S. Kawai et al., State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: Existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBVPCR, J MED VIROL, 64(4), 2001, pp. 410-418
Authors:
Kanda, T
Yokosuka, O
Kawal, S
Imazeki, F
Saisho, H
Citation: T. Kanda et al., Sequence-motif analysis of 5 '-untranslated region of GB virus-C in Japanese patients, J GASTR HEP, 15(9), 2000, pp. 1048-1053
Authors:
Shiratori, Y
Perelson, AS
Weinberger, L
Imazeki, F
Yokosuka, O
Nakata, R
Ihori, M
Hirota, K
Ono, N
Kuroda, H
Motojima, T
Nishigaki, M
Omata, M
Citation: Y. Shiratori et al., Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta, J HEPATOL, 33(2), 2000, pp. 313-322
Authors:
Shiratori, Y
Kato, N
Yoshida, H
Nakata, R
Ihori, M
Imazeki, F
Yokosuka, O
Kawase, T
Katamoto, T
Unuma, T
Nakamura, A
Ikegami, F
Hirota, K
Omata, M
Citation: Y. Shiratori et al., Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapy, DIG DIS SCI, 45(3), 2000, pp. 565-574
Authors:
Fujiwara, K
Yokosuka, O
Ehata, T
Imazeki, F
Saisho, H
Citation: K. Fujiwara et al., PCR-SSCP analysis of 5 '-nontranslated region of hepatitis A viral RNA: Comparison with clinicopathological features of hepatitis A, DIG DIS SCI, 45(12), 2000, pp. 2422-2427
Authors:
Seta, T
Yokosuka, O
Imazeki, F
Tagawa, M
Saisho, H
Citation: T. Seta et al., Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients, J MED VIROL, 60(1), 2000, pp. 8-16
Authors:
Shiratori, Y
Moriyama, M
Imazeki, F
Ohkubo, H
Tanaka, N
Arakawa, Y
Yoshida, H
Yokosuka, O
Shibuya, A
Matsuzaki, K
Hashimoto, E
Hayashi, N
Hirata, K
Ohashi, Y
Omata, M
Citation: Y. Shiratori et al., A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients, LIVER, 20(4), 2000, pp. 271-280
Authors:
Shiratori, Y
Imazeki, F
Moriyama, M
Yano, M
Arakawa, Y
Yokosuka, O
Kuroki, T
Nishiguchi, S
Sata, M
Yamada, G
Fujiyama, S
Yoshida, H
Omata, M
Citation: Y. Shiratori et al., Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy, ANN INT MED, 132(7), 2000, pp. 517-524
Authors:
Shiratori, Y
Kato, N
Yoshida, H
Imazeki, F
Okano, K
Yokosuka, O
Omata, M
Citation: Y. Shiratori et al., How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C?, J GASTR HEP, 14(1), 1999, pp. 79-84
Authors:
Yokosuka, O
Kojima, H
Imazeki, F
Tagawa, M
Saisho, H
Tamatsukuri, S
Omata, M
Citation: O. Yokosuka et al., Spontaneous negativation of serum hepatitis C virus RNA is a rare event intype C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years, J HEPATOL, 31(3), 1999, pp. 394-399
Authors:
Kojima, H
Yokosuka, O
Kato, N
Shiina, S
Imazeki, F
Saisho, H
Shiratori, Y
Omata, M
Citation: H. Kojima et al., Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens, J HEPATOL, 31(3), 1999, pp. 514-520
Authors:
Kawai, S
Yokosuka, O
Kanda, T
Imazeki, F
Maru, Y
Saisho, H
Citation: S. Kawai et al., Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor Monitor assay, J MED VIROL, 58(2), 1999, pp. 121-126
Authors:
Honda, A
Yokosuka, O
Ehata, T
Tagawa, M
Imazeki, F
Saisho, H
Citation: A. Honda et al., Detection of mutations in the enhancer 2/core promoter region of hepatitisB virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status, J MED VIROL, 57(4), 1999, pp. 337-344
Authors:
Yoshida, H
Shiratori, Y
Moriyama, M
Arakawa, Y
Ide, T
Sata, M
Inoue, O
Yano, M
Tanaka, M
Fujiyama, S
Nishiguchi, S
Kuroki, T
Imazeki, F
Yokosuka, O
Kinoyama, S
Yamada, G
Omata, M
Citation: H. Yoshida et al., Interferon therapy reduces the risk for hepatocellular carcinoma: Nationalsurveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan, ANN INT MED, 131(3), 1999, pp. 174